SEHK:1810
SEHK:1810Tech

Is Xiaomi (SEHK:1810) Fairly Priced After Recent Mixed Share Price Performance?

If you are wondering whether Xiaomi's current share price reflects its true worth, you are not alone and this article is designed to help you frame that question clearly. Xiaomi's stock has seen mixed recent returns, with a 0.4% decline over 7 days, a 7.4% decline over 30 days and a 6.0% decline year to date, while still posting a 10.2% return over 1 year, a very large 3 year return and a 22.3% return over 5 years. Recent coverage has focused on how Xiaomi sits within the global smartphone...
SEHK:9889
SEHK:9889Banks

January 2026's Top Asian Penny Stocks To Watch

As we enter 2026, Asian markets are experiencing a wave of investor optimism, with major indices reaching new highs despite ongoing geopolitical tensions. This backdrop presents an intriguing opportunity for investors exploring the realm of penny stocks—companies that may be small or relatively unknown but hold potential for significant growth. Though the term "penny stock" might sound outdated, these investments can still offer surprising value when backed by strong financial health. In this...
SEHK:9966
SEHK:9966Biotechs

A Look At Alphamab Oncology (SEHK:9966) Valuation After KN035 Regulatory Milestone In Biliary Tract Cancer

The latest development at Alphamab Oncology (SEHK:9966) involves China’s regulator formally accepting its new drug application for KN035, in combination with Gemcitabine and Oxaliplatin, for first-line treatment of unresectable or metastatic biliary tract cancer. See our latest analysis for Alphamab Oncology. After the NMPA accepted the KN035 filing, Alphamab Oncology’s HK$10.28 share price sits alongside a 1-year total shareholder return of 216.31%, while the 90-day share price return of a...